Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular events in neuroendocrine prostate cancer development
Yong Wang, Yu Wang, Xinpei Ci, et al.
Nature Reviews Urology (2021) Vol. 18, Iss. 10, pp. 581-596
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
Zhenduo Shi, Kun Pang, Zhuo‐Xun Wu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 102
Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer
Hanling Wang, Ni Li, Qiuli Liu, et al.
Cancer Cell (2023) Vol. 41, Iss. 7, pp. 1345-1362.e9
Closed Access | Times Cited: 74
Nanotechnological Approaches in Prostate Cancer Therapy: Integration of engineering and biology
Milad Ashrafizadeh, Shahin Aghamiri, Shing Cheng Tan, et al.
Nano Today (2022) Vol. 45, pp. 101532-101532
Open Access | Times Cited: 60
Molecular mechanisms underlying the development of neuroendocrine prostate cancer
Shiqin Liu, Busola R. Alabi, Qingqing Yin, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 57-68
Open Access | Times Cited: 44
Current and emerging therapies for neuroendocrine prostate cancer
Busola R. Alabi, Shiqin Liu, Tanya Stoyanova
Pharmacology & Therapeutics (2022) Vol. 238, pp. 108255-108255
Closed Access | Times Cited: 41
Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer
Diana Simão, Kevin Zarrabi, José Leão Mendes, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1412-1412
Open Access | Times Cited: 27
Nanotherapeutics for prostate cancer treatment: A comprehensive review
Ruimin Hu, Lan Jin, Dinglin Zhang, et al.
Biomaterials (2024) Vol. 305, pp. 122469-122469
Closed Access | Times Cited: 10
The tale of SOX2: Focusing on lncRNA regulation in cancer progression and therapy
Peng Huang, Feng Wen, YiShan Li, et al.
Life Sciences (2024) Vol. 344, pp. 122576-122576
Closed Access | Times Cited: 9
Prostate Cancer: A Journey Through Its History and Recent Developments
Hamza Mallah, Zania Diabasana, Sina Soultani, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 194-194
Open Access | Times Cited: 1
Prostate cancer epigenetics — from pathophysiology to clinical application
Vera Constâncio, João Lobo, José Pedro Sequeira, et al.
Nature Reviews Urology (2025)
Closed Access | Times Cited: 1
Prognostic value of circulating Chromogranin A in prostate cancer: a systematic review and meta-analysis
Xiaoying Tang, Zhenyu Liu, Liangdong Song, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
The role of transcription factors in prostate cancer progression
Jongeun Lee, Yoontae Lee
Molecules and Cells (2025), pp. 100193-100193
Open Access | Times Cited: 1
Novel hormone therapies for advanced prostate cancer: understanding and countering drug resistance
Zhipeng Wang, Jie Wang, Dengxiong Li, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101232-101232
Open Access | Times Cited: 1
Tumor Microenvironment and Cancer Metastasis
Yulong Li, Han Wu
IntechOpen eBooks (2025)
Closed Access | Times Cited: 1
Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer
Hanling Wang, Sulin Zhang, Qiang Pan‐Hammarström, et al.
Nature Cancer (2025)
Closed Access | Times Cited: 1
Chemotherapy in metastatic castration-resistant prostate cancer: Current scenario and future perspectives
Vicenç Ruiz de Porras, Albert Font, Àlvaro Aytés
Cancer Letters (2021) Vol. 523, pp. 162-169
Closed Access | Times Cited: 45
Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
Juan Carlos Triviño Pardo, Vicenç Ruiz de Porras, Joan Gil, et al.
Nutrients (2022) Vol. 14, Iss. 4, pp. 851-851
Open Access | Times Cited: 33
Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and Perspective
Jian Huang, Biyun Lin, Benyi Li
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 32
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity
Thomas C. Westbrook, Xiangnan Guan, Eva S. Rodansky, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30
A potassium-chloride co-transporter promotes tumor progression and castration resistance of prostate cancer through m6A reader YTHDC1
Shuai Yuan, Shaohua He, Luyao Li, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 21
The nerve growth factor-delivered signals in prostate cancer and its associated microenvironment: when the dialogue replaces the monologue
Marzia Di Donato, Pia Giovannelli, Antimo Migliaccio, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Overexpression of RACGAP1 by E2F1 Promotes Neuroendocrine Differentiation of Prostate Cancer by Stabilizing EZH2 Expression
Zhengshuai Song, Qi Cao, Bin Guo, et al.
Aging and Disease (2023) Vol. 14, Iss. 5, pp. 1757-1757
Open Access | Times Cited: 20
Gastrin-releasing peptide receptor (GRPR) as a novel biomarker and therapeutic target in prostate cancer
Honghu Zhang, Lin Qi, Yi Cai, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 7
Marine Natural Products with Activities against Prostate Cancer: Recent Discoveries
Eleonora Montuori, Caroline Anna Clara Hyde, Francesco Crea, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1435-1435
Open Access | Times Cited: 16
HMMR promotes prostate cancer proliferation and metastasis via AURKA/mTORC2/E2F1 positive feedback loop
Kaixuan Guo, Cheng Liu, Juanyi Shi, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top